NCT05129618 - Tolerability Study of Panosyl Isomaltooligosaccharides (PIMO), in Subjects With Chronic Idiopathic Constipation (CIC) | Biotech Hunter

Enrollment

172

Participants

Timeline

Start Date

September 23, 2021

Primary Completion Date

June 12, 2022

Study Completion Date

June 12, 2022

Conditions

Constipation Chronic Idiopathic

Interventions

DIETARY_SUPPLEMENT

MHS 1031

prebiotic syrup in individual sachets containing 1g (1.4 ml) of panosyl-isomaltooligosaccharides

OTHER

placebo

liquid combination formulation of Neotame 7.92 mcg/g, phosphoric acid, and sterile water, designed to have the same degree of sweetness as the test material, provided in individual sachets containing 1.4 ml.

Trial Locations (1)

20109

Remote Study - by phone and online, Manassas